Penserra Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-35,496
| Closed | -$84K | – | 1374 |
|
|
2023
Q3 | $84K | Sell |
35,496
-13,531
| -28% | -$32K | ﹤0.01% | 932 |
|
|
2023
Q2 | $86K | Buy |
49,027
+28,817
| +143% | +$50.5K | ﹤0.01% | 968 |
|
|
2023
Q1 | $62K | Sell |
20,210
-8,380
| -29% | -$25.7K | ﹤0.01% | 831 |
|
|
2022
Q4 | $151K | Sell |
28,590
-42,997
| -60% | -$227K | ﹤0.01% | 742 |
|
|
2022
Q3 | $252K | Buy |
+71,587
| New | +$252K | 0.01% | 565 |
|
|
2021
Q4 | – | Sell |
-1,425
| Closed | -$10K | – | 1582 |
|
|
2021
Q3 | $10K | Buy |
1,425
+10
| +0.7% | +$70 | ﹤0.01% | 1363 |
|
|
2021
Q2 | $14K | Buy |
1,415
+15
| +1% | +$148 | ﹤0.01% | 1243 |
|
|
2021
Q1 | $13K | Sell |
1,400
-20
| -1% | -$186 | ﹤0.01% | 1010 |
|
|
2020
Q4 | $15K | Buy |
+1,420
| New | +$15K | ﹤0.01% | 885 |
|